Clinical Evaluation of Resin Matrix Ceramic Posterior Crowns

January 22, 2023 updated by: Universidad Complutense de Madrid

Clinical Evaluation of Resin Matrix Ceramic and Zirconia Posterior Crowns

The objectives of the present prospective randomized clinical study are to evaluate and to compare the survival and success rates, possible biological and technical complications, and the clinical performance of metal-ceramic, monolithic zirconia and resin-matrix posterior crowns.

The null hypothesis is that no differences would be found between the parameters studied for each type of restoration.

Study Overview

Detailed Description

A total of 60 patients, in whom the placement of a crown in the posterior region of the maxilla or mandible was indicated, will be included in the study. The patients will be recruited from the Master of Buccofacial Prostheses and Occlusion (School of Dentistry; University Complutense of Madrid). Prior to treatment, patients will be informed regarding the aims of the study, the clinical procedure, the materials used, the risks and benefits of ceramic restorations and the alternatives to the proposed treatment. All the patients will be provided with a written informed consent for the inclusion in this study, Ninety posterior crowns will be produced and assigned in parallel and randomly to either resin-matrix ceramic, zirconia or metal-ceramic restorations. Three experienced prosthodontists will treat the patients. Abutment preparation will be performed in a standardized manner: circumferentially chamfer (1 mm in width), axial reduction of 1 mm, and an occlusal reduction of 1.5 to 2 mm. The tapering angle between the axial walls will be approximately 10- to 12- degrees. Full-arch digital impressions will be taken using an Intraoral Scanner. The restorations will be cemented with a resin cement. The restorations will be examined at one week (baseline), 1, 2, and 3 years, by two researchers who were not involved in the restorative treatment

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: MARIA JESUS SUAREZ, PhD
  • Phone Number: 0034 913942029
  • Email: mjsuarez@ucm.es

Study Contact Backup

  • Name: JESUS PELAEZ, PhD
  • Phone Number: 0034 913942029
  • Email: jpelaezr@ucm.es

Study Locations

      • Madrid, Spain, 28040
        • Recruiting
        • Faculty of Odontology
        • Contact:
          • MARIA JESUS SUAREZ, PhD
          • Phone Number: 0034 913942029
          • Email: mjsuarez@ucm.es
        • Contact:
        • Sub-Investigator:
          • BENJAMIN SERRANO, PhD
        • Sub-Investigator:
          • ESTHER GONZALO, PhD
        • Sub-Investigator:
          • CARLOS LOPEZ-SUAREZ, PhD
        • Sub-Investigator:
          • VERONICA RODRIGUEZ, PhD
        • Sub-Investigator:
          • CELIA TOBAR, PhD
        • Sub-Investigator:
          • JORGE ARELLANO, Bachelor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • One posterior tooth (molar or premolar) to be crowned,
  • Vital abutments or abutments with sufficient endodontic treatment
  • Abutment not crowned previously
  • Periodontally healthy abutments with no signs of bone resorption or periapical disease --
  • Adequate occlusogingival height
  • Stable occlusion, and the presence of natural dentition in the antagonist arch.

Exclusion Criteria:

  • Patients who present reduced crown length (less than 3 mm occlusogingival height
  • Poor oral hygiene, high caries activity, active periodontal disease or bruxism.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Resin-matrix ceramic
To assess the survival and clinical performance of resin-matrix posterior crows in a complete digital flow
posterior crowns
Other Names:
  • VarseoSmile crown
ACTIVE_COMPARATOR: Monolithic zirconia
To assess the survival and clinical performance of monolithic zirconia posterior crows in a complete digital flow
posterior crowns
ACTIVE_COMPARATOR: Metal-ceramic
To assess the survival and clinical performance of metal-ceramic posterior crows in a complete digital flow
posterior crowns

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival and success rates
Time Frame: 3 years
Survival and success rates with Kaplan Meier method
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of restorations at baseline
Time Frame: Baseline
The restorations will be assessed using the California Dental Association's assessment system, for the surface and color, anatomic form, and margin integrity.
Baseline
Quality of restorations at 1 year
Time Frame: 1 year
The restorations will be assessed using the California Dental Association's assessment system, for the surface and color, anatomic form, and margin integrity.
1 year
Quality of restorations at 2 years
Time Frame: 2 years
The restorations will be assessed using the California Dental Association's assessment system, for the surface and color, anatomic form, and margin integrity.
2 years
Quality of restorations at 3 years
Time Frame: 3 years
The restorations will be assessed using the California Dental Association's assessment system, for the surface and color, anatomic form, and margin integrity.
3 years
Plaque Index (PI) at baseline
Time Frame: Baseline
Plaque Index (PI) of the abutment and control tooth will be assessed. A score of 0 to 3 will be assigned. Higher score will mean a worse outcome
Baseline
Plaque Index (PI) at 1 year
Time Frame: 1 year
Plaque Index (PI) of the abutment and control tooth will be assessed. A score of 0 to 3 will be assigned. Higher score will mean a worse outcome
1 year
Plaque Index (PI) at 2 years
Time Frame: 2 years
Plaque Index (PI) of the abutment and control tooth will be assessed. A score of 0 to 3 will be assigned. Higher score will mean a worse outcome
2 years
Plaque Index (PI) at 3 years
Time Frame: 3 years
Plaque Index (PI) of the abutment and control tooth will be assessed. A score of 0 to 3 will be assigned. Higher score will mean a worse outcome
3 years
Gingival Index (GI) at baseline
Time Frame: Baseline
Gingival Index (GI) of the abutment and control tooth will be assessed. A score of 0 to 3 will be assigned. Higher score will mean a worse outcome
Baseline
Gingival Index (GI) at 1 year
Time Frame: 1 year
Gingival Index (GI) of the abutment and control tooth will be assessed. A score of 0 to 3 will be assigned. Higher score will mean a worse outcome
1 year
Gingival Index (GI) at 2 years
Time Frame: 2 years
Gingival Index (GI) of the abutment and control tooth will be assessed. A score of 0 to 3 will be assigned. Higher score will mean a worse outcome
2 years
Gingival Index (GI) at 3 years
Time Frame: 3 years
Gingival Index (GI) of the abutment and control tooth will be assessed. A score of 0 to 3 will be assigned. Higher score will mean a worse outcome
3 years
Probing depth at baseline
Time Frame: Baseline
Probing depth of the abutment and control tooth. A score of 0 to 4 will be assigned. Higher score will mean a worse outcome
Baseline
Probing depth at 1 year
Time Frame: 1 year
Probing depth of the abutment and control tooth. A score of 0 to 4 will be assigned. Higher score will mean a worse outcome
1 year
Probing depth at 2 years
Time Frame: 2 years
Probing depth of the abutment and control tooth. A score of 0 to 4 will be assigned. Higher score will mean a worse outcome
2 years
Probing depth at 3 years
Time Frame: 3 years
Probing depth of the abutment and control tooth. A score of 0 to 4 will be assigned. Higher score will mean a worse outcome
3 years
Margin stability at baseline
Time Frame: Baseline
To assess the gingival margin stability of the abutment and control tooth throughout the evaluation period (subgingival, isogingival or supragingival)
Baseline
Margin stability at 1 year
Time Frame: 1 year
To assess the gingival margin stability of the abutment and control tooth throughout the evaluation period (subgingival, isogingival or supragingival)
1 year
Margin stability at 2 years
Time Frame: 2 years
To assess the gingival margin stability of the abutment and control tooth throughout the evaluation period (subgingival, isogingival or supragingival)
2 years
Margin stability at 3 years
Time Frame: 3 years
To assess the gingival margin stability of the abutment and control tooth throughout the evaluation period (subgingival, isogingival or supragingival)
3 years
Patient satisfaction at 3 years
Time Frame: 3 years
Subjective patient satisfaction using Visual analogue scale (VAS) ranged from 0 (worst possile result) to 10 (best possible result)
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: MARIA JESUS SUAREZ, PhD, University Complutense of Madrid
  • Principal Investigator: JESUS PELAEZ, PhD, University Complutense of Madrid

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

January 25, 2023

Primary Completion (ANTICIPATED)

July 1, 2023

Study Completion (ANTICIPATED)

October 30, 2026

Study Registration Dates

First Submitted

January 22, 2023

First Submitted That Met QC Criteria

January 22, 2023

First Posted (ACTUAL)

February 1, 2023

Study Record Updates

Last Update Posted (ACTUAL)

February 1, 2023

Last Update Submitted That Met QC Criteria

January 22, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • UCM
  • 4195120 (OTHER_GRANT: BEGO GmbH)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Materials

Clinical Trials on Monolithic zirconia

Subscribe